Jorge Trejo-Gutierrez is a Cardiology physician. OpenAlex indexes 32 publications with 458 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 San Pablo Rd S
Jacksonville, FL 322241865
Telephone
904-953-2000Provider last certified this registry record 10 Oct 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.3%Statin20.4%Rosuvastatin Calcium56%Atorvastatin Calcium44%Part D≥62 patientsCholesterol absorption inhibitor16.9%Ezetimibe100%Part D≥84 patients+ 10 more classes in this area
Blood & clotting
11.5%Factor Xa inhibitor6.9%Eliquis73%Xarelto27%Part D<11 patientsP2Y12 inhibitor4.7%Clopidogrel100%Part D≥21 patientsMetabolism & gastrointestinal
3.2%SGLT2 inhibitor2.3%Jardiance100%Part D<11 patientsBiguanide (metformin)0.9%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular Risk Assessment: Practical Tips for the Internal Medicine Specialist
European Journal of Internal Medicine
2025 - A Community-Informed Virtual World-Based Cardiac Rehabilitation Program as an Extension of Center-Based Cardiac Rehabilitation
Journal of Cardiopulmonary Rehabilitation and Prevention
2022 - Incidence and risk factors of angiotensin-converting enzyme inhibitor–induced angioedema
Annals of Allergy Asthma & Immunology
2021 - Incidence And Risk Factors of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Large Case-Control Study
Journal of Allergy and Clinical Immunology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”